NCT01902758View on ClinicalTrials.gov

Drug Combination on Exercise Performance at High Altitude

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Acute Mountain Sickness
Interventions
DRUG

ambrisentan and theophylline

DRUG

placebo

placebo for comparison group

Trial Locations (1)

59812

Montana Center for Work Physiology and Exercise Metabolism, Missoula

All Listed Sponsors
lead

University of Montana

OTHER

NCT01902758 - Drug Combination on Exercise Performance at High Altitude | Biotech Hunter | Biotech Hunter